Compare INDP & LAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INDP | LAND |
|---|---|---|
| Founded | 2000 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 438.4M | 361.5M |
| IPO Year | 2021 | 2010 |
| Metric | INDP | LAND |
|---|---|---|
| Price | $3.18 | $6.25 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $8.17 |
| AVG Volume (30 Days) | 211.2K | ★ 1.2M |
| Earning Date | 11-13-2026 | 11-10-2026 |
| Dividend Yield | N/A | ★ 8.98% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $88,339,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.66 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 3.66 |
| 52 Week Low | $0.92 | $6.15 |
| 52 Week High | $5.96 | $13.00 |
| Indicator | INDP | LAND |
|---|---|---|
| Relative Strength Index (RSI) | 50.79 | 22.23 |
| Support Level | $2.17 | N/A |
| Resistance Level | $3.71 | $9.83 |
| Average True Range (ATR) | 0.34 | 0.35 |
| MACD | -0.02 | -0.06 |
| Stochastic Oscillator | 51.34 | 5.26 |
Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.
Gladstone Land Corp is an externally-managed, agricultural REIT. It is mainly in the business of owning and leasing farmland. It manages operations in one reporting segment: Real Estate Rental Operations. It is focused on the ownership of farms and farm-related properties that are leased on a triple-net basis to tenants with a good operating history and deep farming resources. The farmland is predominantly concentrated in locations where farmers are able to grow either fresh produce or annual row crops (e.g., certain berries and vegetables), which are typically planted and harvested annually, or certain permanent crops (e.g., almonds, blueberries, pistachios, and wine grapes). To a much lesser extent, it also owns farms that grow certain commodity crops (e.g., corn and beans).